Recombinant Bifidobacterium longum N-acetylhexosamine kinase (NahK), E. coli

Cat. No.: XET001Q

Recombinant Bifidobacterium longum N-acetylhexosamine kinase (NahK), E. coli

Synonym: NahK; LnpB; N-Acetylhexosamine 1-kinase; N-Acetylgalactosamine 1-kinase; N-Acetylglucosamine 1-kinase

  • Enzyme Commission Number: 2.7.1.162
Product Size
5 units; 20 units; 100 units
Price
Datasheet
MSDS
Properties
Description
It is an recombinant Bifidobacterium longum N-acetylhexosamine kinase (NahK) produced in E. coli. This product can be used to study the mode of action of the enzyme and its potential inhibitors, and can also be used as a glycoengineering tool to modify glycoproteins in vitro.
Molecular Weight
40 KDa
Unit Definition
One unit will catalyze the formation of 1 μmol GlcNAc-1-P from GlcNAc and ATP per minute at 37°C.
Source
Bifidobacterium longum
Form
Lyophilized powder
Purity
>95%, determined by SDS-PAGE.
Applications
Study the mode of action of the enzyme and its potential inhibitors and as a glycoengineering tool to modify glycoproteins in vitro.
Storage
Store at -20°C.
Safety Information
Personal Protective Equipment
Gloves, eyeshields, N95 mask
Related Products

Thanksgiving 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0